SFX by Ex Libris Inc.

Title:	The small GTPase Rab11 co-localizes with {alpha}-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity
Source:	Human Molecular Genetics [0964-6906] Chutna, O yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Eisbach, Sibylle E. "alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology." Journal of molecular medicine 91.6 (2013): 693-703.
description	2.	Gao, K. "The VPS35 gene and Parkinson's disease." Movement disorders 28.5 (2013): 569-575.
description	3.	Li, G. "HDAC6 Î±-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases." Journal of the neurological sciences 304.1-2 (2011): 1-8.
description	4.	Goellner, B. "The synaptic cytoskeleton in development and disease." Developmental neurobiology 72.1 (2012): 111-125.
description	5.	Pipinos, Iraklis I I. "Mitochondrial defects and oxidative damage in patients with peripheral arterial disease." Free radical biology & medicine 41.2 (2006): 262-269.
description	6.	Nakamura, K. "Physiology versus pathology in Parkinson's disease." Proceedings of the National Academy of Sciences of the United States of America 104.29 (2007): 11867-11868.
description	7.	Stoessl, A. Jon, S. "Gene therapy for Parkinson's disease: early data." The lancet 369.9579 (2007): 2056-2058.
description	8.	Schneider, Susanne A. "Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)." Current neuropharmacology 11.1 (2013): 59-79.
description	9.	Schneider, A. "Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders." Cell and tissue research 352.1 (2012): 33-47.
description	10.	Hatano, M. "VPS35 mutation in Japanese patients with typical Parkinson's disease." Movement disorders 27.11 (2012): 1413-1417.
description	11.	Uzdensky, A. "Dynamics of signaling, cytoskeleton and cell cycle regulation proteins in glioblastoma cells after sub-lethal photodynamic treatment : Antibody microarray study." Biochimica et biophysica acta. G, General subjects 1820.BBA (2012): 795-803.
description	12.	Stiles, J. "The effects of injury to dynamic neural networks in the mature and developing brain." Developmental psychobiology 54.3 (2012): 343-349.
description	13.	Katsuno, M. "TGF-beta signaling in neurodegenerative diseases." 臨床神経学 51.11 (2011): 982-985.
description	14.	Vilario-Gell, C. "VPS35 Mutations in Parkinson Disease." American journal of human genetics 89.1 (2011): 162-167.
description	15.	Jenner, P. "Etiology and pathogenesis of Parkinson's disease." Movement disorders 26.6 (2011): 1049-1055.
description	16.	Szebenyi, G. "Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport." Neuron 40.1 (2003): 41-52.
description	17.	Tang, B. "SIRT2, tubulin deacetylation, and oligodendroglia differentiation." Cell motility and the cytoskeleton 65.3 (2008): 179-182.
description	18.	Hazan, J. "Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia." Nature genetics 23.3 (1999): 296-303.
description	19.	Cookson, M. "Cell systems and the toxic mechanism(s) of alpha-synuclein." Experimental Neurology 209.1 (2008): 5-11.
description	20.	Gaudet, P. "Measuring the impact of Parkinson's disease: an occupational therapy perspective." Canadian journal of occupational therapy 69.2 (2002): 104-13.